MacroGenics
MGNX
#8677
Rank
A$0.24 B
Marketcap
A$3.92
Share price
-6.51%
Change (1 day)
25.65%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.24 Billion

As of March 2026 MacroGenics has a market cap of A$0.24 Billion. This makes MacroGenics the world's 8677th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.24 B63.69%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Mar 23rd, 2026 the market cap of MacroGenics was reported to be:

A$0.26 Billion
by Nasdaq info icon info icon
A$0.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$219.99 B 88,287.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.159 T 465,712.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$269.44 B 108,153.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$245.95 B 98,715.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$412.72 B 165,721.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$167.65 B 67,259.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.25 B 402.57%๐Ÿ‡บ๐Ÿ‡ธ USA